文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症心脑血管急症

铁死亡在危重症中的临床意义:一篇叙述性综述

Clinical implications of ferroptosis in critical illness: a narrative review.
PubMed 文献 · J Intensive Care · 2026-06-29
一句话结论铁死亡是一种铁依赖、脂质过氧化驱动的调节性细胞死亡,在脓毒症、COVID-19、缺血再灌注损伤和神经系统急症中可能参与器官功能障碍,目前证据多来自临床前模型,检测与靶向治疗存在局限。

尽管ICU救治取得重大进展,患者死亡率仍高、幸存者功能预后常较差,亟需基于机制的创新方法。精准医学是有前景的范式,调节性细胞死亡(RCD)可能提供靶向干预的新切入点。铁死亡是铁依赖的RCD,由细胞膜内过度脂质过氧化驱动,其机制独特性与潜在可逆性使其在急性动态疾病状态中尤其相关。本叙述性综述探讨铁死亡在危重症中的作用,聚焦脓毒症、COVID-19、缺血再灌注损伤和神经系统急症等高影响疾病,概述其分子机制并讨论其如何导致多系统器官功能障碍。迄今多数见解来自临床前模型,新兴临床数据提示转化潜力;文章重点介绍关键研究、讨论检测与治疗靶向的当前局限,并思考铁死亡评估如何帮助塑造ICU精准医学的未来。

要点

  • 铁死亡是铁依赖的调节性细胞死亡,由细胞膜内过度脂质过氧化驱动,机制上区别于其他RCD且可能可逆。
  • 综述聚焦脓毒症、COVID-19、缺血再灌注损伤和神经系统急症等高影响危重症。
  • 铁死亡可能参与多系统器官功能障碍,但迄今多数见解来自临床前模型。
  • 新兴临床数据提示转化潜力,但检测与治疗靶向存在当前局限。
  • 铁死亡评估可能有助于塑造ICU精准医学的未来。

适用人群与场景

  • ICU收治的危重症患者,涵盖脓毒症、COVID-19、缺血再灌注损伤和神经系统急症等高影响疾病。

研究设计与关键结果

  • 本叙述性综述探讨铁死亡在危重症中的作用,聚焦脓毒症、COVID-19、缺血再灌注损伤和神经系统急症。
  • 文章概述铁死亡的分子机制,并讨论其如何导致多系统器官功能障碍。
  • 迄今多数见解来自临床前模型,新兴临床数据提示转化潜力。

证据类型、等级与局限

  • 证据类型:叙述性综述。
  • 局限:多数见解来自临床前模型;检测与治疗靶向存在当前局限。

对床旁实践的改变

  • 作者认为铁死亡评估可能有助于塑造ICU精准医学的未来。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Despite major advances in care for patients admitted to the intensive care unit (ICU), mortality remains high and functional outcomes for ICU survivors are often poor. The persistent burden underscores the need for innovative, mechanism-based approaches. Precision medicine has emerged as a promising paradigm in critical illness, and regulated cell death (RCD) may offer a novel entry point for targeted interventions. Among the various RCD pathways, ferroptosis, an iron-dependent form of RCD driven by excessive lipid peroxidation within cellular membranes, has gained increasing attention. Its mechanistic distinctiveness from other RCDs and potential reversibility make it particularly relevant in acute, dynamic disease states. In this narrative review, we explore the role of ferroptosis in critical care, focusing on high-impact conditions such as sepsis, COVID-19, ischaemia-reperfusion injury, and neurological emergencies. We outline the molecular mechanisms of ferroptosis and discuss how it may contribute to organ dysfunction across systems. While most insights to date stem from preclinical models, emerging clinical data suggest translational potential. We highlight key studies, discuss current limitations in detection and therapeutic targeting, and consider how the evaluation of ferroptosis could help shape the future of precision medicine in the ICU.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Stroobants T, Willemart C, Walravens M, et al. Clinical implications of ferroptosis in critical illness: a narrative review. J Intensive Care. 2026. PMID: 42374546. doi:10.1186/s40560-026-00899-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。